STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and co-produce biosimilars for the U.S. market.
The company will also launch biosimilar Hyrimoz with Novartis' Sandoz from next year at a list price that is more than 80% lower to AbbVie's blockbuster arthritis drug Humira.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Global stock market correction likely before year-end: Reuters pollBy Hari Kishan BENGALURU (Reuters) - Global stock markets are heading for a correction in coming months, though overall they should post marginal gains ...
Read more »